Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- In-licensing
- View
NCE's - Small molecules indicated for inflammation/autoimmune disorders
Palau Pharma is seeking small molecules at the late preclinical stage or clinical phase I
Full description
Palau Pharma is seeking to in-license NCE's indicated for the treatment of inflammation and autoimmune disorders. The company is interested in small molecules either at the late pre-clinical stage or clinical phase I, that have strong patent protection.
Palau would prefer the molecules to be delivered orally but would consider topical, transdermal or oral delivery with local exposure.
The current inflammation/autoimmune market has worldwide sales of €500 - 1000mn.
Development status
Preclinical
Type of business relationship sought
Licensing or acquisition of a inflammation/autoimmune focused NCE
Licensing contact
Heidi Sisniega
Head
Business Development & Licensing
Head
Business Development & Licensing
Company details
Palau Pharma (Spin-out of Grupo Uriach)
PALAU PHARMA is a newly created biopharmaceutical company devoted to the discovery and development of small molecules for the treatment of inflammatory and autoimmune conditions.
PALAU PHARMA is a newly created biopharmaceutical company devoted to the discovery and development of small molecules for the treatment of inflammatory and autoimmune conditions.
Related reports
Are you looking for reports related to this particular subject. Our Reports section is the best place to start.
Related items
- Inflammation/autoimmune commercialized drugs
- NCEs, new patented formulations and products
- Esmolol, Cyclosporine, Ketoprofen & Tramadol injections
- Biologic Entities in clinical development, registered, novel or bio-generic/follow on.
- Partners/companies looking for a strategic partnership to give them privileged access to hospital markets in Europe.
Related categories
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us